Ferumoxytol for iron deficiency anemia in  patients undergoing hemodialysis. The FACT randomized controlled trial
.

CONCLUSION: Long-term administration of ferumoxytol has noninferior efficacy and a similar safety profile to iron sucrose when used to treat IDA in patients with CKD undergoing hemodialysis.
.
PMID: 30802204 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - February 25, 2019 Category: Urology & Nephrology Authors: Macdougall IC, Strauss WE, Dahl NV, Bernard K, Li Z Tags: Clin Nephrol Source Type: research